lorazepam has been researched along with alprazolam in 100 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 26 (26.00) | 18.7374 |
1990's | 35 (35.00) | 18.2507 |
2000's | 18 (18.00) | 29.6817 |
2010's | 14 (14.00) | 24.3611 |
2020's | 7 (7.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
Abraham, MH; Acree, WE; Ibrahim, A | 1 |
Artursson, P; Bergström, CA; Draheim, R; Holmén, AG; Wassvik, CM | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Abdelkafi, H; Ait Ouarab, L; Barbier, J; Buisson, DA; Caramelle, L; Cintrat, JC; Clerget, A; Gillet, D; Michau, A; Montoir, D; Ngadjeua, F; Pons, V | 1 |
Loeffler, PM | 1 |
Cotreau, MM; Greenblatt, DJ; Kaplan, GB | 1 |
Beck, O; Borg, S; Hjemdahl, P; Lafolie, P; Odelius, G; Wirbing, P | 1 |
Ahrens, TN; Baumgartner, WA; Cutler, NR; Hill, VA; Sramek, JJ | 1 |
Bourin, M; Bradwejn, J; Colombel, MC; Hascoet, M; Mansouri, B | 1 |
Miller, LG | 1 |
Ancill, RJ; Carlyle, WW; Holliday, SG; Liang, RA | 1 |
Friedman, H; Greenblatt, DJ; Redmond, DE | 1 |
Adriaensen, H; Crombez, G; Kupers, R | 1 |
Galpern, WR; Greenblatt, DJ; Miller, LG; Shader, RI | 1 |
Krsiak, M; Sulcova, A | 1 |
Morse, WH; Teeple, ES; Wettstein, JG | 1 |
Wettstein, JG | 1 |
Balon, R; Fox, I; Pohl, R; Rickels, K; Schweizer, E; Yeragani, VK | 1 |
Fernández-Guardiola, A; Fernández-Mas, R; Jurado, JL | 1 |
Blyden, GT; Greenblatt, DJ; Scavone, JM | 2 |
Charney, DS; Woods, SW | 1 |
Abernethy, DR; Greenblatt, DJ; Morse, DS; Shader, RI | 1 |
Bjornsson, TD; Ellinwood, EH; Heatherly, DG; Kilts, C; Nikaido, AM | 1 |
Allen, RM | 1 |
Alderdice, MT; Marunycz, JD; Napoliello, MJ; Newton, RE | 1 |
Geller, AM; Lucki, I; Rickels, K | 1 |
Cohn, JB; Wilcox, CS | 1 |
Ellinwood, EH; Heatherly, DG; Nikaido, AM | 1 |
Bjornsson, TD; Ellinwood, EH; Heatherly, DG; Nikaido, AM | 1 |
Cole, JO; Orzack, MH | 1 |
Beake, B; Bird, M; Cole, JO; Dessain, E; Friedman, L; McEachern, J; Orzack, MH | 1 |
Dorsey, C; Greenblatt, DJ; Harmatz, JS; Shader, RI | 1 |
Bell, J; Bickford-Wimer, PC; de la Garza, R; Egan, M; Freedman, R | 1 |
Case, G; Fox, I; Rickels, K; Schweizer, E | 1 |
Gabrielli, WF; Goodwin, DW; Kumar, R; Mac, DS | 1 |
Harrison, C; Hindmarch, I; Subhan, Z | 1 |
Charney, DS; Goodman, WK | 1 |
Aranko, K | 1 |
Ruiz, AT | 1 |
Berchou, R; Block, RI | 1 |
Ator, NA; Brady, JV; Griffiths, RR; Lamb, RJ; Lukas, SE | 1 |
Juhl, RP; Kroboth, PD; Phillips, JP; Smith, RB; Stoehr, GP; Wender, DB | 1 |
Greenblatt, DJ; Ochs, HR; Verburg-Ochs, B | 1 |
Baghai, T; Bossert-Zaudig, S; Faltermaier-Temizel, M; Laakman, G; Lorkowski, G | 1 |
Banks, W; Digenis, GA; Dobbs, FR; Fleishaker, JC; Franceschini, MP; Kinsey, BM; Tewson, TJ; Valentine, AD | 1 |
Harrison, EM; Jackson, JL; Muntjewerff, ND; O'Hanlon, JF; Quint, PJ; Vermeeren, A | 1 |
Busto, U; Kaplan, HL; Romach, M; Sellers, E; Somer, G | 1 |
Needleman, SB; Porvaznik, M | 1 |
Byrnes, JJ; Greenblatt, DJ; Miller, LG; Shader, RI | 1 |
Andrenyak, DM; Huang, W; Moody, DE; Rollins, DE | 1 |
Burke, TF; Miller, LG; Moerschbaecher, JM | 1 |
Coplan, JD; Gorman, JM; Papp, LA; Tiffon, L | 1 |
Calvello, R; Cannuscio, B; Covelli, V; Greco, B; Jirillo, E; Maffione, AB | 1 |
Barbhaiya, R; Chaikin, PC; Folan, MM; Kroboth, PD; Lush, RM; Salazar, DE; Shukla, UA | 1 |
Boomsma, F; Moleman, P; Noten, JB; Pepplinkhuizen, L; Tulen, JH; van den Berg, F | 1 |
Davidson, JR | 1 |
Bussmann, HB; Man in 't Veld, AJ; Pepplinkhuizen, L; Tulen, JH; van Steenis, HG | 1 |
Kroboth, PD; McAuley, JW | 1 |
Busto, UE; Kaplan, HL; Romach, MK; Sellers, EM; Somer, G | 1 |
DaSilva, D; Deptula, D; Greenblatt, DJ; Hernando, R; Pomara, N; Tun, H | 1 |
Man in't Veld, AJ; Tulen, JH | 1 |
Bussmann, JB; Stam, HJ; Tulen, JH; van Herel, EC | 1 |
Roach, JT; Sufka, KJ; Watson, GS | 1 |
Rawson, MJ; Rawson, NS | 1 |
Busto, UE; Gomez-Mancilla, B; Greenblatt, DJ; Kaplan, HL; Sellers, EM; Wright, CE; Zawertailo, L | 1 |
Christiaens, F; Dellers, I; Denis, B; Lessire, H; Vankeerberghen, L; Verborgh, C | 1 |
Allain, H; Bentué-Ferrer, D; Bourin, M; Reymann, JM; Tribut, O; Vasar, E | 1 |
Beigh, A; Mir, B; Naqib, A | 1 |
Greenblatt, DJ; Nemeroff, CB; Pomara, N; Ritchie, JC; Sidtis, JJ; Willoughby, LM | 1 |
Bourin, M | 1 |
Collins, CH; Collins, KE; Faria, AM | 1 |
Kulvanich, P; Ongpipattanakul, B; Sila-on, W; Vardhanabhuti, N | 1 |
Mandrioli, R; Mercolini, L; Raggi, MA | 1 |
Jogani, V; Misra, A; Naik, S; Porecha, S; shah, T | 1 |
Feltner, DE; Herman, B; Lydiard, RB; Rickels, K | 1 |
Chronister, CW; Goldberger, BA; Merves, ML | 1 |
Gunn, J; Kriger, S; Terrell, AR | 1 |
Argyraki, M; Ekonomopoulou, MT; Iakovidou-Kritsi, Z; Polatoglou, E; Stephanidou-Stephanatou, J; Tsoleridis, CA | 1 |
Akritopoulou, K; Ekonomopoulou, MT; Iakovidou-Kritsi, Z; Mourelatos, C | 1 |
Abrahamowicz, M; Čapek, R; Sylvestre, MP; Tamblyn, R | 1 |
Adams, JL; Blaschke, T; Dell, RM; Der, JS; Finkle, WD; Greenland, S; Ridgeway, G; VanRiper, KB; Wang, Z | 1 |
Bian, B; Gorevski, E; Guo, JJ; Kelton, CM; Martin Boone, JE | 1 |
Abdelmalak, F; Bornmann, C; Iyengar, S; LaRocca, T | 1 |
Cherner, M; Grelotti, DJ; Heaton, RK; Letendre, S; Ma, Q; Saloner, R; Sundermann, EE; Tyree, G | 1 |
Falcon, M; Fernadez-Lopez, L; Luna, A; Mancini, R; Pellegrini, M; Rotolo, M | 1 |
Chunamchai, S; Suteparuk, S; Thumtecho, S; Wainipitapong, S | 1 |
Coulter, C; Garnier, M; Moore, C | 1 |
Hao, Y; Tang, B; Wang, K; Wang, Z; Yang, F | 1 |
Adhikari, S; Barron, LP; Bhatnagar, A; Bowes, DA; Coronado-Apodaca, KG; Driver, EM; Halden, RU; Kumar, R; Martínez-Ruiz, M; McCall, KL; Melchor-Martínez, EM; Ng, KT; Oyervides-Muñoz, MA; Parra-Saldivar, R; Piper, BJ; Smith, T; Sosa-Hernandez, JE | 1 |
Guo, D; Kossintseva, I; Zloty, DM | 1 |
8 review(s) available for lorazepam and alprazolam
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Oral benzodiazepines and conscious sedation: a review.
Topics: Administration, Oral; Alprazolam; Ambulatory Surgical Procedures; Anti-Anxiety Agents; Conscious Sedation; Diazepam; Flurazepam; Humans; Lorazepam; Midazolam; Oxazepam; Premedication; Receptors, GABA-A; Temazepam; Triazolam | 1992 |
Chronic benzodiazepine administration: from the patient to the gene.
Topics: Alprazolam; Animals; Benzodiazepines; Clonazepam; Down-Regulation; Drug Tolerance; Flumazenil; Humans; Lorazepam; Mice; Receptors, GABA-A; RNA, Messenger; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors; Up-Regulation | 1991 |
Review of the side-effect profile of buspirone.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Trials as Topic; Clorazepate Dipotassium; Diazepam; Dizziness; Double-Blind Method; Drug Evaluation; Fatigue; Headache; Humans; Lorazepam; Pyrimidines | 1986 |
Comparative study of the abuse liability of alprazolam, lorazepam, diazepam, methaqualone, and placebo.
Topics: Adolescent; Adult; Alprazolam; Arousal; Diazepam; Euphoria; Female; Humans; Lorazepam; Male; Methaqualone; Risk Factors; Substance-Related Disorders | 1988 |
Use of benzodiazepines in panic disorder.
Topics: Alprazolam; Benzodiazepines; Clonazepam; Humans; Lorazepam; Panic Disorder; Treatment Outcome | 1997 |
Progesterone: does it affect response to drug?
Topics: Alprazolam; Contraceptives, Oral; Drug Interactions; Female; Humans; Lorazepam; Middle Aged; Progesterone; Receptors, GABA-A; Temazepam; Triazolam | 1997 |
Benzodiazepine metabolism: an analytical perspective.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Azepines; Benzodiazepines; Bromazepam; Chromatography, High Pressure Liquid; Diazepam; Humans; Lorazepam; Mass Spectrometry; Midazolam; Triazolam | 2008 |
33 trial(s) available for lorazepam and alprazolam
Article | Year |
---|---|
Agitation in the demented elderly: a role for benzodiazepines?
Topics: Aged; Alprazolam; Dementia; Double-Blind Method; Female; Humans; Lorazepam; Male; Motor Activity; Psychomotor Agitation; Substance Withdrawal Syndrome | 1991 |
The effects of a single oral dose of lorazepam and alprazolam on reaction times in young healthy volunteers.
Topics: Administration, Oral; Adult; Alprazolam; Double-Blind Method; Female; Humans; Lorazepam; Male; Reaction Time | 1991 |
Lorazepam vs. alprazolam in the treatment of panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Double-Blind Method; Fear; Female; Humans; Lorazepam; Male; Mental Disorders; Panic; Randomized Controlled Trials as Topic | 1990 |
Effects of 1 week administration of two benzodiazepines on the sleep and early daytime performance of normal subjects.
Topics: Adult; Alprazolam; Attention; Humans; Lorazepam; Male; Reaction Time; Sleep | 1989 |
Benzodiazepine treatment of panic disorder: a comparison of alprazolam and lorazepam.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Double-Blind Method; Fear; Humans; Lorazepam; Panic; Random Allocation | 1989 |
Interaction of propoxyphene with diazepam, alprazolam and lorazepam.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Dextropropoxyphene; Diazepam; Drug Interactions; Female; Half-Life; Humans; Kinetics; Lorazepam; Male; Metabolic Clearance Rate; Middle Aged | 1985 |
Comparative pharmacokinetics and pharmacodynamics of lorazepam, alprazolam and diazepam.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Diazepam; Dose-Response Relationship, Drug; Drug Tolerance; Humans; Kinetics; Lorazepam; Male; Psychomotor Performance; Receptors, GABA-A | 1985 |
Review of the side-effect profile of buspirone.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Trials as Topic; Clorazepate Dipotassium; Diazepam; Dizziness; Double-Blind Method; Drug Evaluation; Fatigue; Headache; Humans; Lorazepam; Pyrimidines | 1986 |
Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study.
Topics: Adolescent; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Trials as Topic; Double-Blind Method; Fatigue; Female; Humans; Lorazepam; Male; Middle Aged; Pyrimidines; Sleep Stages | 1986 |
Benzodiazepine pharmacodynamics: evidence for biophase rate limiting mechanisms.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Cognition; Diazepam; Humans; Lorazepam; Male; Psychomotor Performance | 1987 |
Potential for abuse of alprazolam.
Topics: Alprazolam; Clinical Trials as Topic; Diazepam; Double-Blind Method; Humans; Lorazepam; Methaqualone; Random Allocation; Substance-Related Disorders | 1988 |
Comparative study of the abuse liability of alprazolam, lorazepam, diazepam, methaqualone, and placebo.
Topics: Adolescent; Adult; Alprazolam; Arousal; Diazepam; Euphoria; Female; Humans; Lorazepam; Male; Methaqualone; Risk Factors; Substance-Related Disorders | 1988 |
Comparative single-dose kinetics and dynamics of lorazepam, alprazolam, prazepam, and placebo.
Topics: Adult; Alprazolam; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Intelligence Tests; Lorazepam; Male; Mental Recall; Nordazepam; Placebos; Prazepam; Random Allocation; Time Factors | 1988 |
Lorazepam vs. alprazolam in the treatment of panic disorder.
Topics: Adolescent; Adult; Agoraphobia; Alprazolam; Fear; Female; Humans; Lorazepam; Male; Mental Disorders; Middle Aged; Panic | 1988 |
Metronidazole impairs clearance of phenytoin but not of alprazolam or lorazepam.
Topics: Adult; Alprazolam; Drug Interactions; Female; Humans; Lorazepam; Male; Metronidazole; Phenytoin; Random Allocation | 1988 |
Anxiolytics and memory: a comparison of lorazepam and alprazolam.
Topics: Adult; Alprazolam; Amnesia; Double-Blind Method; Humans; Lorazepam; Male; Memory; Memory, Short-Term; Placebos; Psychomotor Performance | 1987 |
Alprazolam and lorazepam single and multiple-dose effects on psychomotor skills and sleep.
Topics: Adult; Alprazolam; Benzodiazepines; Female; Flicker Fusion; Humans; Lorazepam; Psychomotor Performance; Reaction Time; Sleep | 1986 |
Task-dependent development of cross-tolerance to psychomotor effects of lorazepam in man.
Topics: Adult; Alprazolam; Benzodiazepines; Diazepam; Drug Tolerance; Female; Humans; Lorazepam; Male; Nitrazepam; Psychomotor Performance; Temazepam | 1985 |
A double-blind study of alprazolam and lorazepam in the treatment of anxiety.
Topics: Adolescent; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Lorazepam; Male; Middle Aged; Random Allocation | 1983 |
Treatment of depressive outpatients with lorazepam, alprazolam, amytriptyline and placebo.
Topics: Adult; Aged; Alprazolam; Amitriptyline; Antidepressive Agents; Depression; Female; Humans; Lorazepam; Male; Middle Aged; Placebo Effect; Psychiatric Status Rating Scales; Time Factors; Treatment Outcome | 1995 |
Comparison of acute alprazolam (0.25, 0.50 and 1.0 mg) effects versus those of lorazepam 2 mg and placebo on memory in healthy volunteers using laboratory and telephone tests.
Topics: Adolescent; Adult; Alprazolam; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Flicker Fusion; Humans; Lorazepam; Male; Memory; Mental Processes; Psychomotor Performance; Reaction Time; Space Perception; Verbal Learning | 1995 |
Coadministration of nefazodone and benzodiazepines: I. Pharmacodynamic assessment.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Arousal; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Humans; Lorazepam; Male; Mental Recall; Metabolic Clearance Rate; Piperazines; Psychomotor Performance; Triazolam; Triazoles | 1995 |
Effects of alprazolam and lorazepam on catecholaminergic and cardiovascular activity during supine rest, mental load and orthostatic challenge.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Blood Pressure; Cross-Over Studies; Double-Blind Method; Epinephrine; Heart Rate; Humans; Lorazepam; Male; Norepinephrine; Posture; Thinking | 1996 |
A novel tool to quantify physical activities: ambulatory accelerometry in psychopharmacology.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Cross-Over Studies; Heart Rate; Humans; Lorazepam; Male; Motor Activity; Psychopharmacology | 1997 |
A controlled trial of ondansetron, a 5-HT3 antagonist, in benzodiazepine discontinuation.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety; Double-Blind Method; Female; Humans; Lorazepam; Male; Middle Aged; Ondansetron; Patient Compliance; Psychiatric Status Rating Scales; Substance Withdrawal Syndrome | 1998 |
The acute and chronic performance effects of alprazolam and lorazepam in the elderly: relationship to duration of treatment and self-rated sedation.
Topics: Aged; Alprazolam; Anti-Anxiety Agents; Double-Blind Method; Female; Humans; Lorazepam; Male; Memory; Middle Aged; Psychomotor Performance | 1998 |
Noninvasive indices of autonomic regulation after alprazolam and lorazepam: effects on sympathovagal balance.
Topics: Acetylcholine; Adult; Alprazolam; Anti-Anxiety Agents; Autonomic Nervous System; Cross-Over Studies; Double-Blind Method; Endocrine Glands; Galvanic Skin Response; Humans; Lorazepam; Male; Neurotransmitter Agents; Sympathetic Nervous System | 1998 |
Quantification of physical activities by means of ambulatory accelerometry: a validation study.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Data Collection; Heart Rate; Humans; Lorazepam; Male; Motor Activity; Psychophysiology; Reproducibility of Results; Videotape Recording | 1998 |
A comparative pharmacokinetic and dynamic evaluation of alprazolam sustained-release, bromazepam, and lorazepam.
Topics: Adult; Affect; Alprazolam; Anti-Anxiety Agents; Bromazepam; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Humans; Logistic Models; Lorazepam; Male; Middle Aged; Psychomotor Performance | 2000 |
A comparative evaluation of the effects of oral lorazepam, alprazolam and diazepam on venous admixture.
Topics: Administration, Oral; Adult; Alprazolam; Blood Gas Analysis; Diazepam; Female; Humans; Hypnotics and Sedatives; Lorazepam; Male; Middle Aged; Preanesthetic Medication | 2002 |
Interdose elevation in plasma cortisol during chronic treatment with alprazolam but not lorazepam in the elderly.
Topics: Aged; Aged, 80 and over; Alprazolam; Analysis of Variance; Double-Blind Method; Drug Interactions; Female; Humans; Hydrocortisone; Lorazepam; Male; Middle Aged | 2004 |
[Disinhibition effects of benzodiazepines].
Topics: Alprazolam; Anti-Anxiety Agents; Attention; Drug Tolerance; Female; Humans; Inhibition, Psychological; Locomotion; Lorazepam; Male; Psychometrics; Serotonin | 2003 |
Efficacy and Safety of Anxiolytics in Mohs Micrographic Surgery: A Randomized, Double-Blinded, Placebo-Controlled Trial.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety; Diazepam; Double-Blind Method; Gabapentin; Humans; Lorazepam; Melatonin; Mohs Surgery; Pregabalin | 2023 |
61 other study(ies) available for lorazepam and alprazolam
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Molecular characteristics for solid-state limited solubility.
Topics: Chemical Phenomena; Chemistry, Physical; Molecular Structure; Multivariate Analysis; Pharmaceutical Preparations; Regression Analysis; Solubility | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Structure-Activity Relationship Studies of Retro-1 Analogues against Shiga Toxin.
Topics: Benzodiazepinones; Golgi Apparatus; HeLa Cells; Humans; Protein Transport; Shiga Toxins; Structure-Activity Relationship | 2020 |
Effects of benzodiazepine administration on A1 adenosine receptor binding in-vivo and ex-vivo.
Topics: Alprazolam; Animals; Benzodiazepines; Brain; In Vitro Techniques; Lorazepam; Male; Mice; Receptors, Purinergic | 1992 |
Detection of benzodiazepine intake in therapeutic doses by immunoanalysis of urine: two techniques evaluated and modified for improved performance.
Topics: Adult; Alprazolam; Benzodiazepines; Chlordiazepoxide; False Negative Reactions; Flunitrazepam; Fluorescence Polarization Immunoassay; Humans; Immunoenzyme Techniques; Lorazepam; Male; Middle Aged; Nitrazepam; Triazolam | 1992 |
Detection of benzodiazepines in human hair by radioimmunoassay.
Topics: Adult; Alprazolam; Benzodiazepines; Diazepam; Female; Hair; Humans; Lorazepam; Male; Middle Aged; Radioimmunoassay | 1992 |
Comparison of behavioral effects after single and repeated administrations of four benzodiazepines in three mice behavioral models.
Topics: Alprazolam; Animals; Anxiety; Behavior, Animal; Benzodiazepines; Bromazepam; Dose-Response Relationship, Drug; Drug Tolerance; Electroshock; Lorazepam; Male; Mice; Motor Activity; Muscle Relaxation; Placebos; Sleep | 1992 |
Comparative pharmacokinetics of alprazolam and lorazepam in humans and in African Green Monkeys.
Topics: Adolescent; Adult; Alprazolam; Animals; Chlorocebus aethiops; Half-Life; Humans; Lorazepam; Male; Species Specificity | 1991 |
Differential effects of chronic lorazepam and alprazolam on benzodiazepine binding and GABAA-receptor function.
Topics: Alprazolam; Animals; Benzodiazepines; Brain Chemistry; Flumazenil; Lorazepam; Male; Mice; Receptors, GABA-A | 1990 |
Differential effects of six structurally related benzodiazepines on some ethological measures of timidity, aggression and locomotion in mice.
Topics: Aggression; Alprazolam; Animals; Anti-Anxiety Agents; Behavior, Animal; Clonazepam; Lorazepam; Male; Mice; Motor Activity; Nitrazepam; Oxazepam; Shyness; Structure-Activity Relationship; Triazolam | 1990 |
Respiratory effects of benzodiazepine-related drugs in awake rhesus monkeys.
Topics: Administration, Inhalation; Alprazolam; Animals; Anti-Anxiety Agents; Appetite Depressants; Benzodiazepines; Buspirone; Carbolines; Carbon Dioxide; Drug Therapy, Combination; Female; Flumazenil; Lorazepam; Macaca mulatta; Male; Pentobarbital; Plethysmography; Pyrazoles; Respiration | 1990 |
Unusual behavioral profile of alprazolam in squirrel monkeys.
Topics: Alprazolam; Animals; Azides; Benzodiazepines; Dose-Response Relationship, Drug; Electroshock; Flumazenil; Injections, Intravenous; Lorazepam; Male; Psychomotor Performance; Saimiri | 1990 |
Lack of effect of influenza vaccine on the pharmacokinetics of antipyrine, alprazolam, paracetamol (acetaminophen) and lorazepam.
Topics: Acetaminophen; Adult; Alprazolam; Antipyrine; Drug Administration Schedule; Drug Interactions; Female; Humans; Influenza Vaccines; Lorazepam; Male; Middle Aged; Time Factors | 1989 |
Tranquilizers and sedative/hypnotics: appropriate use in the elderly.
Topics: Aged; Alprazolam; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Half-Life; Humans; Hypnotics and Sedatives; Lorazepam; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders; Temazepam; Tranquilizing Agents | 1986 |
Chronic use of benzodiazepines and psychomotor and cognitive test performance.
Topics: Adult; Affect; Aged; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Clorazepate Dipotassium; Cognition Disorders; Diazepam; Female; Flicker Fusion; Humans; Lorazepam; Male; Memory Disorders; Middle Aged; Neuropsychological Tests; Psychomotor Disorders | 1986 |
Comparative pharmacodynamics of benzodiazepines.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Diazepam; Humans; Kinetics; Lorazepam; Male; Psychomotor Performance; Triazolam | 1987 |
Increased central noradrenergic activity during benzodiazepine withdrawal: an electrophysiological study.
Topics: Action Potentials; Alprazolam; Animals; Cerebellum; Diazepam; Lorazepam; Norepinephrine; Purkinje Cells; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome | 1988 |
A case of alprazolam, but not lorazepam, inducing manic symptoms.
Topics: Adult; Alprazolam; Anxiety Disorders; Bipolar Disorder; Female; Humans; Lorazepam; Panic | 1987 |
Alprazolam and lorazepam effects on memory acquisition and retrieval processes.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Discrimination, Psychological; Double-Blind Method; Flicker Fusion; Humans; Learning; Lorazepam; Male; Memory; Psychomotor Performance; Reaction Time | 1984 |
Benzodiazepines: drug discrimination and physiological dependence.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Benzodiazepines; Bromazepam; Diazepam; Discrimination Learning; Dose-Response Relationship, Drug; Generalization, Stimulus; Humans; Lorazepam; Papio; Pentobarbital; Substance Withdrawal Syndrome; Substance-Related Disorders; Triazolam | 1984 |
Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kinetics.
Topics: Administration, Oral; Adult; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Chromatography, Gas; Drug Interactions; Ethinyl Estradiol; Female; Half-Life; Humans; Kinetics; Lorazepam; Smoking; Temazepam; Triazolam | 1984 |
Propranolol interactions with diazepam, lorazepam, and alprazolam.
Topics: Adolescent; Adult; Alprazolam; Benzodiazepines; Biotransformation; Chromatography, High Pressure Liquid; Diazepam; Drug Interactions; Female; Humans; Injections, Intravenous; Kinetics; Lorazepam; Male; Nordazepam; Propranolol | 1984 |
Studies with [11C]alprazolam: an agonist for the benzodiazepine receptor.
Topics: Alprazolam; Binding, Competitive; Brain; Carbon Radioisotopes; Cerebellum; Frontal Lobe; Functional Laterality; GABA-A Receptor Agonists; Humans; Kinetics; Lorazepam; Receptors, GABA-A; Reference Values; Temporal Lobe; Time Factors; Tomography, Emission-Computed | 1995 |
Clinical aspects of chronic use of alprazolam and lorazepam.
Topics: Alprazolam; Ambulatory Care; Anxiety Disorders; Depressive Disorder; Drug Administration Schedule; Female; Humans; Lorazepam; Male; Mental Disorders; Middle Aged; Patient Acceptance of Health Care; Recurrence; Risk Factors; Sex Factors; Substance Withdrawal Syndrome; Substance-Related Disorders | 1995 |
Identification of parent benzodiazepines by gas chromotography/mass spectroscopy (GC/MS) from urinary extracts treated with B-glucuronidase.
Topics: Alprazolam; Benzodiazepines; Chlordiazepoxide; Clonazepam; Diazepam; Gas Chromatography-Mass Spectrometry; Glucuronidase; Humans; Lorazepam; Oxazepam; Triazolam | 1995 |
Chronic benzodiazepine administration. XII. Anticonvulsant cross-tolerance but distinct neurochemical effects of alprazolam and lorazepam.
Topics: Alprazolam; Animals; Anticonvulsants; Brain Chemistry; Cerebral Cortex; Down-Regulation; Drug Tolerance; Flumazenil; Hippocampus; Lorazepam; Male; Mice; Pentylenetetrazole; Receptors, GABA-A; Seizures | 1993 |
Immunoassay detection of nordiazepam, triazolam, lorazepam, and alprazolam in blood.
Topics: Alprazolam; Anti-Anxiety Agents; Cross Reactions; Humans; Immunoassay; Lorazepam; Nordazepam; Triazolam | 1993 |
Acute effects of benzodiazepines on operant behavior and in vivo receptor binding in mice.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Binding, Competitive; Conditioning, Operant; Dose-Response Relationship, Drug; Flumazenil; Lorazepam; Male; Mice; Receptors, GABA-A; Reinforcement Schedule | 1994 |
Augmentation strategies with tricyclic or fluoxetine treatment in seven partially responsive panic disorder patients.
Topics: Adult; Alprazolam; Antidepressive Agents, Tricyclic; Desipramine; Drug Therapy, Combination; Female; Fluoxetine; Humans; Imipramine; Lorazepam; Male; Panic Disorder; Retrospective Studies; Treatment Outcome | 1994 |
In vivo effects of alprazolam and lorazepam on the immune response in patients with migraine without aura.
Topics: Adolescent; Adult; Alprazolam; Cytotoxicity, Immunologic; Female; Humans; Immune System; Lorazepam; Lymphocytes; Male; Middle Aged; Migraine Disorders; Monocytes; Neutrophils; Phagocytosis | 1993 |
Benzodiazepine receptor function in the chick social separation-stress procedure.
Topics: Alprazolam; Analgesia; Animals; Anti-Anxiety Agents; Chickens; Chlordiazepoxide; Disease Models, Animal; Flumazenil; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; Lorazepam; Receptors, GABA-A; Social Behavior; Stress, Psychological | 1999 |
Acute adverse event signalling scheme using the Saskatchewan Administrative health care utilization datafiles: results for two benzodiazepines.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Alprazolam; Anti-Anxiety Agents; Data Collection; Humans; Lorazepam; Middle Aged; Product Surveillance, Postmarketing; Saskatchewan; Time Factors | 1999 |
Successful prolonged cardiopulmonary resuscitation after a combined intoxication with a tricyclic antidepressant, a benzodiazepine and a neuroleptic.
Topics: Adult; Alprazolam; Amitriptyline; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Benzodiazepines; Cardiopulmonary Resuscitation; Emergencies; Female; Humans; Lorazepam; Suicide, Attempted; Thiazines; Time Factors | 2000 |
Role of dopaminergic and serotonergic systems on behavioral stimulatory effects of low-dose alprazolam and lorazepam.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Anxiety Disorders; Dopamine; Dose-Response Relationship, Drug; Lorazepam; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Serotonin; Time Factors | 2001 |
Preparation and characterization of poly(methyltetradecylsiloxane) stationary phases immobilized by gamma radiation onto zirconized silica.
Topics: Acetaminophen; Alprazolam; Benzene Derivatives; Chromatography, High Pressure Liquid; Ibuprofen; Lorazepam; Magnetic Resonance Spectroscopy; Silicon Dioxide; Siloxanes; Spectrophotometry, Infrared; Uracil; Zirconium | 2007 |
Influence of incorporation methods on partitioning behavior of lipophilic drugs into various phases of a parenteral lipid emulsion.
Topics: Alprazolam; Benzodiazepines; Chemistry, Pharmaceutical; Clonazepam; Diazepam; Drug Carriers; Drug Compounding; Fat Emulsions, Intravenous; Hydrogen-Ion Concentration; Lorazepam; Molecular Structure; Particle Size; Phospholipids; Solubility; Soybean Oil; Technology, Pharmaceutical; Ultracentrifugation | 2008 |
Microemulsion based intranasal delivery system for treatment of insomnia.
Topics: Administration, Intranasal; Alprazolam; Animals; Diazepam; Disease Models, Animal; Drug Compounding; Drug Delivery Systems; Humans; Lorazepam; Male; Rats; Rats, Sprague-Dawley; Sleep; Sleep Initiation and Maintenance Disorders | 2009 |
Comparative efficacy of pregabalin and benzodiazepines in treating the psychic and somatic symptoms of generalized anxiety disorder.
Topics: Adolescent; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Dose-Response Relationship, Drug; Female; gamma-Aminobutyric Acid; Humans; Lorazepam; Male; Middle Aged; Pregabalin; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Severity of Illness Index; Treatment Outcome | 2010 |
Quantitation of benzodiazepines in blood and urine using gas chromatography-mass spectrometry (GC-MS).
Topics: Alprazolam; Benzodiazepines; Diazepam; Gas Chromatography-Mass Spectrometry; Humans; Lorazepam; Nordazepam; Oxazepam; Solid Phase Extraction; Triazolam | 2010 |
Simultaneous determination and quantification of 12 benzodiazepines in serum or whole blood using UPLC/MS/MS.
Topics: Alprazolam; Benzodiazepines; Chlordiazepoxide; Chromatography, Liquid; Clonazepam; Flunitrazepam; Humans; Lorazepam; Midazolam; Nordazepam; Oxazepam; Reproducibility of Results; Tandem Mass Spectrometry | 2010 |
Cytogenetic activity of newly synthesized 1,5-benzodiazepines in normal human lymphocyte cultures.
Topics: Adult; Alprazolam; Benzodiazepines; Cell Proliferation; Cells, Cultured; Cytogenetic Analysis; Diazepam; Humans; Lorazepam; Lymphocytes; Mitotic Index; Sister Chromatid Exchange | 2010 |
A comparative study on the cytogenetic activity of three benzodiazepines in vitro.
Topics: Adult; Alprazolam; Benzodiazepines; Cells, Cultured; Chromosome Aberrations; Diazepam; DNA Damage; DNA Repair; Humans; Lorazepam; Lymphocytes; Mutagens; Sister Chromatid Exchange | 2011 |
Assessing the cumulative effects of exposure to selected benzodiazepines on the risk of fall-related injuries in the elderly.
Topics: Accidental Falls; Aged; Alprazolam; Benzodiazepines; Bromazepam; Chlordiazepoxide; Clonazepam; Female; Flurazepam; Humans; Lorazepam; Male; Proportional Hazards Models; Risk Factors; Temazepam | 2012 |
Risk of fractures requiring hospitalization after an initial prescription for zolpidem, alprazolam, lorazepam, or diazepam in older adults.
Topics: Aged; Aged, 80 and over; Alprazolam; Causality; Cohort Studies; Cross-Sectional Studies; Diazepam; Female; Fractures, Bone; Health Surveys; Hip Fractures; Hospitalization; Humans; Hypnotics and Sedatives; Joint Dislocations; Lorazepam; Male; Odds Ratio; Pyridines; Retrospective Studies; Risk; Statistics as Topic; Zolpidem | 2011 |
Long-term Medicaid excess payments from alleged price manipulation of generic lorazepam.
Topics: Alprazolam; Anti-Anxiety Agents; Databases, Factual; Drug Costs; Drug Industry; Drugs, Generic; Fraud; Humans; Legislation, Drug; Lorazepam; Medicaid; United States; United States Federal Trade Commission; Urban Health | 2012 |
Catatonia due to alprazolam withdrawal.
Topics: Alprazolam; Antipsychotic Agents; Catatonia; Comorbidity; Humans; Lorazepam; Male; Middle Aged; Patient Compliance; Psychotic Disorders; Self Medication; Substance Withdrawal Syndrome; Treatment Outcome | 2018 |
Benzodiazepine Use Is Associated With an Increased Risk of Neurocognitive Impairment in People Living With HIV.
Topics: Adult; Aged; Alprazolam; Benzodiazepines; Cross-Sectional Studies; Diazepam; Executive Function; Female; HIV Infections; Humans; Lorazepam; Male; Memory, Short-Term; Mental Recall; Mental Status and Dementia Tests; Middle Aged; Motor Skills; Neurocognitive Disorders; Propensity Score; Retrospective Studies; Self Report; Young Adult | 2019 |
Postmortem Analysis of Benzodiazepines in Human Bone by Gas Chromatography-Mass Spectrometry.
Topics: Alprazolam; Autopsy; Benzodiazepines; Chromatography, Liquid; Clonazepam; Diazepam; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Humans; Liquid-Liquid Extraction; Lorazepam; Nordazepam; Oxazepam; Tandem Mass Spectrometry | 2021 |
Alprazolam and lorazepam overdose and the absence of brainstem reflexes.
Topics: Aged; Alprazolam; Benzodiazepines; Brain Stem; Female; Humans; Lorazepam; Unconsciousness | 2022 |
Rapid Extraction and Qualitative Screening of 30 Drugs in Oral Fluid at Concentrations Recommended for the Investigation of DUID Cases.
Topics: 2-Propanol; 3,4-Methylenedioxyamphetamine; Alprazolam; Amphetamines; Buprenorphine; Carisoprodol; Clonazepam; Cocaine; Codeine; Dronabinol; Fentanyl; Hexanes; Hydrocodone; Hydromorphone; Lorazepam; Meprobamate; Methadone; Methamphetamine; Morphine Derivatives; N-Methyl-3,4-methylenedioxyamphetamine; Nordazepam; Oxazepam; Oxycodone; Oxymorphone; Pharmaceutical Preparations; Phencyclidine; Tandem Mass Spectrometry; Temazepam; Tramadol; Zolpidem | 2022 |
Accumulation and risk prioritization of psychoactive substances in the critically endangered Yangtze finless porpoise.
Topics: Alprazolam; Animals; China; Codeine; Humans; Lorazepam; Lysergic Acid Diethylamide; Methamphetamine; Morphine Derivatives; Porpoises | 2023 |
Occurrence of Z-drugs, benzodiazepines, and ketamine in wastewater in the United States and Mexico during the Covid-19 pandemic.
Topics: Alprazolam; Benzodiazepines; Clonazepam; COVID-19; Diazepam; Humans; Ketamine; Lorazepam; Mexico; Nordazepam; Pandemics; Tandem Mass Spectrometry; Temazepam; United States; Wastewater; Zolpidem | 2023 |